在性传播细菌感染中,抗微生物治疗和耐药性
Jorgen S Jensen1, Magnus Unemo2,3
1Department of Bacteria, Parasites and Fungi, Research Unit for Reproductive Microbiology, Statens Serum Institut, Copenhagen, Denmark. jsj@ssi.dk.
Nature reviews. Microbiology
|March 21, 2024
概括
抗菌素耐药性威胁到治疗性传播感染 (STIs) 的进展. 淋病和mycoplasma genitalium菌株的耐药性增加,以及持续的梅毒易感性,凸显了迫切的公共卫生挑战.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 性传播感染 (STIs) 长期以来一直影响着人类健康,导致严重的发病率和后果.
- 从历史上看,抗微生物药物提供了有效的治疗和控制,减少了感染的传播和长期并发症.
- 然而,抗微生物耐药性和传播动态的增加现在威胁着这些进步.
研究的目的:
- 审查当前在关键性传播性疾病中抗菌素耐药性的现状.
- 评估针对常见病原体的现有治疗方法的疗效,如尼塞利亚淋病,Mycoplasma genitalium,Chlamydia trachomatis和Treponema pallidum.
- 识别对STI治疗和控制的新兴威胁.
主要方法:
- 对流行性传播感染的抗菌素敏感性数据的文献综述.
- 对尼塞利亚淋病,Mycoplasma genitalium,Chlamydia trachomatis和Treponema pallidum的抗菌素耐药性趋势的分析.
- 检查导致抗性和传播的因素.
主要成果:
- 尼塞里亚淋病菌对其最后一线治疗 - - 塞夫特里亚克的耐药性越来越强.
- 由于替代品有限,并且报告了无法治愈的病例,Mycoplasma genitalium感染的治疗变得越来越困难.
- 目前,克拉米迪亚菌和Treponema pallidum (梅毒) 仍然对一线治疗 (分别为四环素/巨和青素) 敏感.
结论:
- 抗菌素耐药性对性传播感染的有效管理构成重大和日益增长的威胁.
- 迫切需要采取战略,以保持当前治疗的疗效,并开发新的治疗方案.
- 持续的监测和研究对于应对不断变化的STI抗菌素耐药性挑战至关重要.
更多相关视频
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
6.4K
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
4.6K
相关概念视频
01:26Sexually Transmitted Infections
306
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
306
00:57Antibiotic Selection
53.4K
Overview
53.4K
01:18Surface Membrane Barriers
1.1K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.1K
01:28Pulmonary Tuberculosis V
179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
396
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
396
01:27Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K